Verastem Inc

Financials

Total assets 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total liabilities 39.08 M21.1 M47.66 M71.19 M130.43 M189.25 M Total equity 115.27 M87.56 M47.39 M57.37 M-28.89 M57.2 M Total liabilities & shareholders' equities 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total debt 19.05 M249 K24.8 M40.09 M40.72 M76.33 M Net debt -144.01 M-97.12 M-61.11 M-95.57 M-46.55 M-128.13 M

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

Haberler

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright, Verastem hissesi için tavsiyesini korudu

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Verastem hissesi, dayanıklı deneme verileriyle BTIG’de Al tavsiyesi aldı

Verastem’in kanser ilacı kombinasyonu 2 yıllık veride dayanıklılık gösterdi

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)

BTIG, Verastem hissesi için Al önerisiyle kapsama başladı

Verastem stock initiated at Buy by BTIG with $19 price target

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?

Jefferies, lansman ilerlemesi sonrası Verastem hisse notunu korudu

Jefferies reiterates Verastem stock rating on launch progress